Pagari Life Science Corp.

New Filing

CIK: 0001993125·Pharmaceuticals·DELAWARE·Filed: May 12, 2026

Total Offering

$300,000

Amount Sold

$97,494

Investors

8

First Sale

Apr 28, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2022
Non-Accredited Investors: No

Related Persons

Name	Role
David Feldker
Stephen Peipert
Marni Zenkewicz
James Wickenhauser

Company

Pagari Life Science Corp.

333 WEST BETHALTO DRIVE

BETHALTA, IL, 62010

314 920 8321

SEC Filing

0001993125-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.